Strategic Advocates’s Axon Enterprise AXON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.41K Sell
15
-53
-78% -$22.2K 0.03% 171
2026
Q1
$28.9K Sell
68
-1,836
-96% -$954K 0.13% 109
2025
Q4
$1.09M Buy
1,904
+48
+3% +$29.8K 0.28% 49
2025
Q3
$1.33M Buy
1,856
+22
+1% +$16.7K 0.35% 45
2025
Q2
$1.52M Sell
1,834
-58
-3% -$39.5K 0.45% 38
2025
Q1
$995K Buy
+1,892
New +$1.11M 0.35% 47
2024
Q1
Sell
-5,757
Closed -$1.49M 131
2023
Q4
$1.49M Sell
5,757
-1,085
-16% -$245K 0.63% 36
2023
Q3
$1.36M Buy
+6,842
New +$1.35M 0.64% 32

Other funds holding AXON

Strategic Advocates's AXON Position: Q2 2026 in Review

Strategic Advocates reduced its Axon Enterprise (AXON) stake by 78% in Q2 2026, selling an estimated $22.2K and leaving 15 shares worth $8.41K. The position accounts for 0.03% of the portfolio, ranked #171.

Strategic Advocates first reported a position in AXON in Q3 2023 and has held it in 8 quarters since. The position peaked at $1.52M in Q2 2025. 1,127 funds tracked by Wall St. Rank hold AXON as of Q2 2026.

  • Strategic Advocates held 15 shares of Axon Enterprise worth $8.41K as of Q2 2026.
  • Strategic Advocates sold 53 Axon Enterprise shares in Q2 2026, an estimated $22.2K.
  • Axon Enterprise made up 0.03% of Strategic Advocates's portfolio in Q2 2026, its #171 holding.
  • Strategic Advocates first reported a position in Axon Enterprise in Q3 2023 and has held it in 8 quarters since.
  • Strategic Advocates's Axon Enterprise position peaked at $1.52M in Q2 2025.
  • 1,127 funds tracked by Wall St. Rank held Axon Enterprise as of Q2 2026.

Based on Strategic Advocates's 13F filing for Q2 2026, filed 13 Aug 2026.